Phase 3 Trial of Epicutaneous Immunotherapy in Toddlers with Peanut AllergyMatthew Greenhawt, Paul Turner, Sayantani Sindher et al.|New England Journal of Medicine|2023Cited by 129
Vaccines and allergic reactions: The past, the current COVID‐19 pandemic, and future perspectivesVanitha Sampath, Kari C. Nadeau, Ioana Agache et al.|Allergy|2021Cited by 113
Efficacy and Safety of Epicutaneous Immunotherapy in Peanut-Allergic Toddlers: Open-Label Extension to EPITOPEMatthew Greenhawt, Christian Vogelberg, Deborah Albright et al.|The Journal of Allergy and Clinical Immunology In Practice|2025Cited by 14
Evaluating Pediatric Macrolide Allergy Using Direct Graded Oral ChallengesCarly Sillcox, Moshe Ben-Shoshan, Sofianne Gabrielli et al.|JAMA Pediatrics|2024Cited by 3